Wenemea

Aarhus, Denmark

Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.

$1.1M raised

Jan 2026

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Wenemea raised?

Wenemea has raised $1.1M in total funding. The most recent round was Grant. The last funding was announced in January 2026.

Who are Wenemea's investors?

Wenemea's investors include Eurostars.

Where is Wenemea headquartered?

Wenemea is headquartered in Aarhus, Denmark.

What does Wenemea do?

Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.

What stage is Wenemea at?

Wenemea is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 21, 2026.

MLA

"Wenemea — Funding & Investors." VCBacked, January 21, 2026, https://www.vcbacked.co/company/wenemea. Accessed July 2, 2026.

APA

VCBacked. (2026). Wenemea — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/wenemea

Wikipedia (cite web)

{{cite web |title=Wenemea — Funding & Investors |url=https://www.vcbacked.co/company/wenemea |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 21, 2026.